Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Mise à jour : Il y a 4 ans
Référence : NCT00436553

Femme et Homme

Extrait

This study evaluated the effect of combination therapy with verteporfin photodynamic therapy and ranibizumab on visual acuity and anatomic outcomes compared to ranibizumab monotherapy and the durability of response observed in patients with choroidal neovascularization secondary to age-related macular degeneration.


Critère d'inclusion

  • Macular degeneration ,Choroidal Neovascularization

Liens